AVE 33.3% 0.2¢ avecho biotechnology limited

it`s the balance sheet stupid, page-96

  1. 5,799 Posts.
    lightbulb Created with Sketch. 737
    Rowser ~ ""Does anyone know efficiency of TPM delivery, or would it be dependant on the drug being transported?""

    Interesting question on TPM's efficiency.

    I think only Esra could answer this properly, but what I can say is that TPM is an amazing technology that has the ability to not only control the output and rate of dosage, but also the depth or structures to which it penetrates into.
    In other words it can be developed to be a systemic application like oxycodene patch delivery a set constant dose over time, or set to bypass the systemic system into soft tissues or nerve receptors like oxygel (proof of concept stage).

    But a confusing aspect is that TPM is not just a trans-dermal delivery system. It can be combined with oral supplements to be taken as tablets or added to food to increase the effectiveness of what's it coupled with.

    I can't give you percentages, but the TPM is very refined, controllable and adaptable.
    Sorry I can't be more specific. Maybe someone else has additional information.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $2.493K 837.9K

Buyers (Bids)

No. Vol. Price($)
25 37471564 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 37366033 28
View Market Depth
Last trade - 12.24pm 12/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.